MPA 446 Pharmaceutical Wholesaler Distribution Services

The State of Rhode Island, through its Department of Administration/Division of Purchases, is issuing a Notice of Cooperative Solicitation (NOC23002519) for Pharmaceutical Wholesaler Distribution Services under Master Price Agreement (MPA) 446. The procurement will utilize awards resulting from MMCAP RFP #32581, seeking pharmaceutical distribution services for state agencies, with a specific focus on Providence County. The solicitation period runs from March 7, 2023, to April 13, 2023, with all proposals due by 3:00:00 PM EDT on the final date. Vendors must submit responses electronically through the Ocean State Procures system, with no alternative submission methods accepted. The delivery terms are specified as Free On Board Destination, with payment terms to be defined by the vendor. While specific evaluation criteria are not detailed in the documents, vendors must register in the Ocean State Procures system and provide appropriate documentation to be considered. The procurement aims to establish a Master Price Agreement subject to Rhode Island State Purchases Act and Procurement Regulations, with services to be provided according to the terms of the MMCAP RFP.

No specific set-aside designations or restrictions on respondent types are explicitly outlined in the solicitation documents. The opportunity appears open to all pharmaceutical wholesaler vendors who can meet the requirements of the MMCAP RFP #32581. While an estimated total contract value is not specified, the state indicates it will collect a contract administrative fee not to exceed 1% of the total annual spend, which will be deposited into a restricted receipt account for procurement technology implementation. The collected fees will support technology for bid submission, processing, online bidder registration, and bid notification. No incumbent vendors are identified in the documents, and no specific integration requirements with existing infrastructure are mentioned. The Master Price Agreement will be available for use by state agencies, potentially providing a significant market opportunity for selected pharmaceutical wholesaler distributors willing to comply with the state's procurement regulations and cooperative solicitation terms.